Shukra Pharmaceuticals Schedules Board Meeting for Q1 Financial Review
Shukra Pharmaceuticals Ltd has announced a meeting of its Board of Directors scheduled for August 11, 2026. The meeting is set to take place at the Company's Registered Office.The primary purpose of the Board Meeting is to consider and approve key corporate matters. A major item on the agenda is the review of the unaudited financial results for the quarter ended on June 30, 2026. This includes reviewing the associated Auditor's Limited Review Report.
The Board meeting will also include discussions regarding any other business with the permission of the Chairman.
Stock Price Movement
Shukra Pharmaceuticals Ltd settled at ₹31.06 in post-market trading on Thursday, edging higher by 3.19%. The shares experienced intraday volatility, ranging from a low of ₹30.02 to a high of ₹32.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.